מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
Levonorgestrel; Ethinylestradiol; Ethinylestradiol; Levonorgestrel; Levonorgestrel
Imbat Limited
G03AB; G03AB03
Levonorgestrel; Ethinylestradiol; Ethinylestradiol; Levonorgestrel; Levonorgestrel
*** AWAITING VALUE ***
Tablet
Product subject to prescription which may be renewed (B)
Progestogens and estrogens, sequential preparations; levonorgestrel and ethinylestradiol
Authorised
2014-07-04
T: INFORMATION FOR THE USER GYNON ® TABLETS estradiol / levonorgestrel) ble using the name Logynon Tablets as Logynon throughout this leaflet. EAFLET CAREFULLY BEFORE YOU MEDICINE. You may need to read it again. urther questions, ask your doctor or s been prescribed for you. Do not pass it ay harm them, even if their symptoms yours. effects gets serious, or if you notice ot listed in this leaflet, please tell your cist. O KNOW ABOUT COMBINED HORMONAL CS): he most reliable reversible methods of sed correctly ease the risk of having a blood clot in eries, especially in the first year or combined hormonal contraceptive of 4 or more weeks d see your doctor if you think you may f a blood clot (see section 2 "Blood AFLET: and what it is used for know before you take Logynon non ts non ack and other information N IS AND WHAT IT IS USED FOR raceptive pill and is used to prevent ins a small amount of two different , namely levonorgestrel and s that contain two hormones are called ED TO KNOW BEFORE YOU TAKE Logynon you should read the ots in section 2. It is particularly symptoms of a blood clot – see section aking Logynon, your doctor will ask you your personal health history and that of he doctor will also measure your blood ng upon your personal situation, may her tests for example a breast exam or opriate. situations are described where you non, or where the reliability of Logynon such situations you should either not d take extra non-hormonal ons, e.g., use a condom or another t use rhythm or temperature methods. unreliable because Logynon alters the dy temperature and of cervical mucus. combined oral contraceptives have a mately 1% per year. The failure rate s are missed or taken incorrectly, if you or when you take certain other medies. HORMONAL CONTRACEPTIVES, DOES NOT INFECTION (AIDS) OR ANY OTHER DISEASE. OGYNON gynon if you have any of the conditions have any of the conditions listed below if you need an operation, or you are off your feet for a long time (see in section 2 "Blood clots") if you have j קרא את המסמך השלם
Health Products Regulatory Authority 03 October 2019 CRN0093FN Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Logynon Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION EACH LIGHT BROWN TABLET CONTAINS: Ethinylestradiol 30 micrograms Levonorgestrel 50 micrograms EACH WHITE TABLET CONTAINS: Ethinylestradiol 40 micrograms Levonorgestrel 75 micrograms EACH OCHRE-COLOURED TABLET CONTAINS: Ethinylestradiol 30 micrograms Levonorgestrel 125 micrograms Excipients of known effect: lactose and sucrose – see leaflet for further information. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated tablet. _Product imported from the UK:_ Each calendar blister contains 6 light brown sugar-coated tablets, 5 white sugar-coated tablets and 10 ochre-coloured sugar-coated tablets. 4 CLINICAL PARTICULARS As per PA1410/005/001 5 PHARMACOLOGICAL PROPERTIES As per PA1410/005/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS lactose maize starch povidone talc sucrose magnesium stearate (E572) polyethylene glycol 6000 calcium carbonate (E170) glycerin (E422) titanium dioxide (E171) ferric oxide pigment yellow (E172) ferric oxide pigment red (E172) montan glycol wax 6.2 INCOMPATIBILITIES Health Products Regulatory Authority 03 October 2019 CRN0093FN Page 2 of 2 Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the blister strips and outer carton of the product as marked in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 30°C. 6.5 NATURE AND CONTENTS OF CONTAINER Cardboard outer containing blister strips. Pack size: 1 x 21 tablets 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER Imbat Limited Unit L2 North Ring Business Park Santry Dublin 9 Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1151/218/001 9 DATE OF FIRST AUTHORISATION/ קרא את המסמך השלם